Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.

Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial. Circ Cardiovasc Interv. 2022 04; 15(4):e010925.

View in: PubMed